Biomarkers in cerebrospinal fluid can identify patients with Alzheimer's disease
Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska ...
Oct 22, 2012
0
0